Financial Disclosure Violations Are Unlikely To Warrant Clinical Holds – FDA
Executive Summary
Violations of FDA's financial disclosure requirements would be unlikely to lead to a clinical hold decision, FDA says in a draft guidance on investigator misconduct and clinical holds